- Amirkia, V. and Heinrich, M., 2014. Alkaloids as drug leads-A predictive structural and biodiversity-based analysis. Phytochemistry Letters, 10: xlviii-liii.
- Briskin, D.P., 2000. Medicinal plants and phytomedicines. Linking plant biochemistry and physiology to human health. Plant physiology, 124: 507-514.
- Brown, S., Clastre, M., Courdavault, V. and O'Connor, S.E., 2015. De novo production of the plant-derived alkaloid strictosidine in yeast. Proceedings of the National Academy of Sciences of the United States of America, 112: 3205-3210.
- Bynum, W.F. and Porter, R., 2013. Companion Encyclopedia of the History of Medicine. Taylor and Francis, Hoboken, 1856p.
- Chemler, J.A. and Koffas, M.A.G., 2008. Metabolic engineering for plant natural product biosynthesis in microbes. Current Opinion in Biotechnology, 19: 597-605.
- Clayden, J., Greeves, N., Warren, S. and Wothers, P., 2001. Organic Chemistry. Oxford University Press, New York, NY, 1264p.
- DeLoache, W.C., Russ, Z.N., Narcross, L., Gonzales, A.M., Martin, V.J.J. and Dueber, J.E., 2015. An enzyme-coupled biosensor enables (S)-reticuline production in yeast from glucose. Nature Chemical Biology, 11: 465-471.
- Galanie, S., Thodey, K., Trenchard, I.J., Interrante, M.F. and Smolke, C.D., 2015. Complete biosynthesis of opioids in yeast. Science, 349(6252): 1095-1100.
- Gesell, A., Chávez, M.L.D., Kramell, R., Piotrowski, M., Macheroux, P. and Kutchan, T.M., 2011. Heterologous expression of two FAD-dependent oxidases with (S)-tetrahydroprotoberberine oxidase activity from Argemone mexicana and Berberis wilsoniae in insect cells. Planta, 233: 1185-1197.
- Hamann, T. and Møller, B.L., 2007. Improved cloning and expression of cytochrome P450s and cytochrome P450 reductase in yeast. Protein Expression and Purification, 56: 121-127.
- Ikezawa, N., Tanaka, M., Nagayoshi, M., Shinkyo, R., Sakaki, T., Inouye, K. and Sato, F., 2003. Molecular cloning and characterization of CYP719, a methylenedioxy bridge-forming enzyme that belongs to a novel P450 family, from cultured Coptis japonica cells. The Journal of Biological Chemistry, 278: 38557-38565.
- Ikezawa, N., Iwasa, K. and Sato, F., 2009. CYP719A subfamily of cytochrome P450 oxygenases and isoquinoline alkaloid biosynthesis in Eschscholzia californica. Plant Cell Reports, 28: 123-133.
- Lee, S.Y., Kim, H.U., Park, J.H., Park, J.M. and Kim, T.Y., 2009. Metabolic engineering of microorganisms: general strategies and drug production. Drug Discovery Today, 14: 78-88.
- Li, Y., Li, S., Thodey, K., Trenchard, I., Cravens, A. and Smolke, C.D., 2018. Complete biosynthesis of noscapine and halogenated alkaloids in yeast. Proceedings of the National Academy of Sciences of the United States of America, 115: E3922-E3931.
- Marner, W.D., 2009. Practical application of synthetic biology principles. Biotechnology Journal, 4: 1406-1419.
- Matsumura, E., Nakagawa, A., Tomabechi, Y., Ikushiro, S., Sakaki, T., Katayama, T., Yamamoto, K., Kumagai, H., Sato, F. and Minami, H., 2018. Microbial production of novel sulphated alkaloids for drug discovery. Scientific Reports, 8: 7980.
- Newman, D.J. and Cragg, G.M., 2012. Natural products as sources of new drugs over the 30 years from 1981 to 2010. Journal of Natural Products, 75: 311-335.
- Oliveira, A.R.M. and Szczerbowski, D., 2009. Quinine: 470 years of history, controversy and science development. Química Nova, 32: 1971-1974.
- Peplow, M., 2016. Synthetic biology's first malaria drug meets market resistance. Nature, 530: 389-390.
- Pham, J.V., Yilma, M.A., Feliz, A., Majid, M.T. and Maffetone, N., 2019. A review of the microbial production of bioactive natural products and biologics. Frontiers in Microbiology, 10: 1404.
- Raskin, I., Ribnicky, D.M., Komarnytsky, S., Ilic, N. and Poulev, A., 2002. Plants and human health in the twenty-first century. Trends in Biotechnology, 20: 522-531.
- Sato, F. and Kumagai, H., 2013. Microbial production of isoquinoline alkaloids as plant secondary metabolites based on metabolic engineering research. Proceedings of the Japan Academy. Series B, Physical and biological sciences, 89: 165-182.
- Schäfer, H. and Wink, M., 2009. Medicinally important secondary metabolites in recombinant microorganisms or plants: progress in alkaloid biosynthesis. Biotechnology Journal, 4: 1684-1703.
- Simmons, J.G., 2002. Doctors and discoveries: Lives that created today's medicine. Houghton Mifflin, Boston, 448p.
- Song, M.C., Kim, E.J., Kim, E., Rathwell, K., Nam, S.J. and Yoon, Y.J., 2014. Microbial biosynthesis of medicinally important plant secondary metabolites. Natural product reports, 31: 1497-1509.
- Townsend, C.A. and Ebizuka, Y., 2010. Natural Products Structural Diversity-I, Secondary Metabolites. Organization and biosynthesis. Elsevier, Boston, 997p.
- Zhou, H., Xie, X. and Tang, Y., 2008. Engineering natural products using combinatorial biosynthesis and biocatalysis. Current Opinion in Biotechnology, 19: 590-596.
- Zhou, K., Qiao, K., Edgar, S. and Stephanopoulos, G., 2015. Distributing a metabolic pathway among a microbial consortium enhances production of natural products. Nature biotechnology, 33: 377-383.
- Ziegler, J., Facchini, P.J., Geissler, R., Schmidt, J., Ammer, C. and Kramell, R., 2009. Evolution of morphine biosynthesis in opium poppy. Phytochemistry, 70: 1696-1707.
)